Option chain shows key data for Scopus BioPharma's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Scopus BioPharma.

Scopus BioPharma (OTC:SCPS) Stock, Option Chain

Scopus BioPharma

Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system. The endocannabinoid system is comprised of chemical compounds, or cannabinoids, that interact with cannabinoid receptors which are located throughout the body. The company product candidates would utilize synthetically-produced cannabinoids as opposed to plant-derived compounds. Its product candidate comprises CO-sTiRNA, which is a STAT3 inhibitor gene therapy and MRI-1867.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ACMR

AEHR

ALVO

AMPX

ATNF

AVYA

BXRX

CACO

CENN

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

Core Scientific, Inc. - Class A Common Stock

CORZ

CVNA

DATS

EDSA

EVLV

GROM

GRRR

HLGN

HSDT

IMRN

LANV

LIPO

LWLG

MGAM

MLKN

OGEN

ORIC

OXBR

PBTS

PLXP

PRQR

RCKT

REKR

SAVA

SCPS

SINT

SOLO

Sunlight Financial Holdings, Inc. Class A Common Stock

SUNL

UIHC

VEDU

VERO

WEST

WETG

WISH

Gainers


	Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.


Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday&#39;s Mid-Day Session

ACLX

AGFY

AKLI

AKRO

ANEB

ANTE

APPH

ARBK

ARDX

ASPU

AXLA

BRDS

CCCC

CELC

CERE

CHPT

CINT

COEP

COSM

CZOO

DOMO

ETNB

FTFT

GEVO

GOSS

GREE

HCTI

HLTH

ICPT

IPDN

IPHA

Citigroup Financial 300% Minupon Princ Protected Nts for Russell 2000 Index

MDGL

MHUA

MINM

Melco Resorts & Entertainment Limited - American Depositary Shares

MLCO

MOND

MRSN

MULN

NEPT

NEWP

NEXA

NOGN

OBSV

OTIC

PERF

PHGE

PRFX

QUMU

RDIB

RELL

RLAY

SEER

SLNO

SMMT

SNPX

TELL

TERN

TRKA

VANI

VKTX

VTGN

ZVSA

Gainers


	Madrigal Pharmaceuticals, Inc.  (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.


Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday&#39;s Mid-Day Session

ADAG

ADBE

AGYS

ALLR

AMAM

AMEH

AUID

AUVI

BVXV

BYSI

CETX

CJJD

COIN

COMS

CRKN

DNUT

DRMA

New Oriental Education & Technology Group

Euda Health Holdings Limited - Ordinary Shares

EUDA

EXAS

FCUV

FFIE

ICVX

MAXR

MLGO

Morgan Stanley Capital Protected Notes for S&P 500 Index

NCRA

NVAX

PHIO

RCRT

SBET

SCHL

SPRY

STRY

STSS

TGTX

VLON

Gainers


	Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.


Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday&#39;s Mid-Day Session

SCOPUS BIOPHARMA INC by Scopus Biopharma, Inc.

Scopus BioPharma Inc

Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) has slammed Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) for its numerous requests to access iPhone-maker&#8217;s software tools, citing potential privacy and security risks.
What Happened: Under the EU&#8217;s Digital Markets Act, Apple is required to allow competitors and app developers to inter-operate with its services or face significant fines.
Meta has so far submitted 15 interoperability requests, more than any other company, seeking extensive access to Apple&#8217;s technology stack, reported Reuters, citing a report in which Cupertino complained about it.
The Tim Cook-led tech giant has expressed concerns that Meta&#8217;s requests could compromise user privacy and security.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42513402/apples-2025-bull-case-can-it-deliver-without-riding-the-ai-wave?itm_source=parsely-api">Apple&#8217;s 2025 Bull Case: Can It Deliver Without Riding The AI Wave?</a>
The company also suggested that the requests are unrelated to the use of Meta&#8217;s external devices like smart glasses and VR headsets.
Apple cited Meta's history of receiving fines in Europe as a reason for its concern.
In response, a Meta spokesperson accused Apple of using privacy as a pretext for anticompetitive behavior. &#8220;Every time Apple is called out for its anticompetitive behavior, they defend themselves on privacy grounds that have no basis in reality.&#8221;
Apple and Meta did not immediately respond to <a href="https://pro.benzinga.com/dashboard">Benzinga's</a> request for comments.
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It Matters: Since 2014, Cook and Meta CEO Mark Zuckerberg have clashed over privacy, business models, and product strategies.
From Facebook&#8217;s Cambridge Analytica scandal to Apple's iOS privacy updates and competing VR headsets, their battle epitomizes the growing tensions between Silicon Valley&#8217;s biggest players.
This year in February, Apple launched its first-generation mixed-reality headset called Vision Pro, and Zuckerberg wasted no time in sharing his thoughts on the device.
&nbsp;&#8220;I don't think that Quest is the better value, I think [Meta&#8217;s] Quest is the better product, period,&#8221; he stated at the time.
In June, <a href="https://www.benzinga.com/news/24/06/39470144/apple-reportedly-said-no-to-metas-offer-for-iphone-ai-integration-due-to-privacy-policy-concerns">Apple reportedly declined Meta&#8217;s proposal</a> to integrate its AI chatbot, Llama, into the iPhone, citing privacy policy concerns. This report came just days after Apple announced a partnership with OpenAI.
In July, Meta CEO Mark Zuckerberg criticized Apple&#8217;s approach, describing it as &#8220;soul-crushing&#8221; and accusing the company of <a href="https://www.benzinga.com/news/24/07/39926076/mark-zuckerberg-slams-tim-cooks-apple-after-cupertino-reportedly-rejected-its-iphone-ai-partnership">trying to limit Meta&#8217;s</a> technological advancements.
Price Action: On Wednesday, Meta&#8217;s stock finished 3.59% lower at $597.19, while Apple saw a decline of 2.14%, ending at $248.05, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Check out more of Benzinga&#8217;s Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/24/12/42525551/ahead-of-trumps-return-to-white-house-us-approves-406m-grant-for-taiwans-chipmaker-globalwafers?itm_source=parsely-api">Ahead Of Trump&#8217;s Return To White House, US Approves $406M Grant For Taiwan&#8217;s Chipmaker GlobalWafers</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.

Tech

Media

AAPL

Apple Slams Meta's Interoperability Demands, Cites Privacy Risks — Instagram Parent Fires Back: Cupertino's Assertions Have 'No Basis In Reality'

Exodus Movement Inc. (NYSEAMERICAN: EXOD) commenced trading on the NYSE American exchange Wednesday, becoming the latest publicly traded company on Wall Street with cryptocurrency as the core business.
What happened: The shares of the self-custodial wallet provider closed 37% higher at $53.50 after getting listed on NYSE American, the sibling exchange to the New York Stock Exchange.
Owned by the New York Stock Exchange, NYSE American specializes in small- and mid-cap equities.
The company, which previously traded on over-the-counter markets, got approval to list its common stock last week.
See Also:<a href="https://www.benzinga.com/24/12/42519107/if-you-invested-1000-in-bitcoin-when-the-first-bitcoin-etf-was-filed-heres-how-much-youd-have-today"> </a><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42560698/microstrategys-aggressive-bitcoin-strategy-raises-eyebrows-in-crypto-community">MicroStrategy&#8217;s Aggressive Bitcoin Strategy Raises Eyebrows In Crypto Community</a>
Why It Matters: Founded in 2015, Exodus is one of the oldest providers of non-custodial cryptocurrency wallets, supporting top coins like Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>).
With its debut, it joined the niche list of Wall Street companies that primarily deal in cryptocurrencies, <a href="https://www.benzinga.com/24/12/42545624/cathie-woods-ark-dumps-coinbase-stock-amid-bitcoin-highs-shopify-holdings-also-cut">including </a>Coinbase, the largest cryptocurrency exchange in the U.S., and <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42453467/japanese-crypto-behemoth-coincheck-enters-wall-street-with-nasdaq-listing">Japan&#8217;s cryptocurrency behemoth</a> Coincheck.
An exchange listing, especially in the U.S., exposes a company to a broader spectrum of institutional and retail investors, thereby increasing its liquidity and visibility.
Photo Courtesy: Maor_Winetrob On Shutterstock.com
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42545656/bitcoin-is-no-manhattan-real-estate-peter-schiff-challenges-microstrategys-micheal-saylor-btc-doesnt-generate-any-income">Bitcoin Is No Manhattan Real Estate, Peter Schiff Challenges MicroStrategy&#8217;s Michael Saylor: &#8216;BTC Doesn&#8217;t Generate Any Income&#8217;</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

EXOD

Crypto Wallet Provider Exodus Makes Wall Street Debut, Shares Pop 37%

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that it has entered into a global exclusive license agreement with Bristol Myers Squibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) for BioArctic's PyroGlutamate-amyloid-beta (PyroGlu-Aβ) antibody program, including BAN1503 and BAN2803, whereof the latter includes BioArctic's BrainTransporter&#x2122;&nbsp;technology.&nbsp;As part of the agreement, BioArctic will receive a USD 100 million upfront payment and up to USD 1.25 billion in milestone payments. BioArctic is also entitled to tiered low double-digit royalties on global product sales.

BRCTF

BioArctic Partners With Bristol Myers Squibb In Licensing Deal For PyroGlutamate-Amyloid-Beta Antibody Program

&#x2A;– PADOVA study showed numerical delay in motor progression and positive trends on multiple secondary and exploratory endpoints –
– Prasinezumab continues to be well tolerated and no new safety signals were observed –
– Genentech is further evaluating the data and will work together with health authorities to determine next steps –

RHHBF

RHHBY

RHHVF

Genentech's Prasinezumab Phase IIb Study Misses Primary Endpoint But Shows Potential In Early Parkinson's Disease

Franco-Nevada Expands Portfolio With Sibanye-Stillwater's Western Limb Mining Operations In $500M Deal

KKR Backs Rebel Foods With Major Investment To Expand World-Class Cloud Kitchen Ecosystem

The U.S. Environmental Protection Agency (EPA) gave California the green light on Wednesday to ban the sale of new gasoline-powered light-duty vehicles by 2035.
What Happened: The agency granted a waiver to California under the Clean Air Act to implement its plan mandating that all new light-duty vehicles delivered in the state by 2035 be plug-in hybrids, battery electric, and hydrogen-powered vehicles. 
The EPA also granted a waiver for the state&#8217;s "Omnibus" low-NOx (nitrogen oxides) regulation aimed at reducing harmful emissions from heavy-duty trucks.
"California has longstanding authority to request waivers from EPA to protect its residents from dangerous air pollution coming from mobile sources like cars and trucks,"&nbsp;said EPA Administrator Michael S. Regan. "Today's actions follow through on EPA's commitment to partner with states to reduce emissions and act on the threat of climate change."
The EPA said in a statement that the opponents of the two waivers failed to show how either program is inconsistent with the Clean Air Act. 
Why It Matters: "Clean cars are here to stay. The Biden-Harris Administration reaffirmed what we've known for decades – California can rise to the challenge of protecting our people by cleaning our air and cutting pollution,&#8221; California Governor Gavin Newsom said.
&#8220;Naysayers like President-elect Trump would prefer to side with the oil industry over consumers and American automakers, but California will continue fostering new innovations in the market."
The California Governor, however, clarified in his statement that the rules are not aimed at gas vehicles already on the road but only attempt to regulate new cars. &#8220;We expect to see internal combustion engine vehicles on California roads past 2050&#8230;,&#8221; he said. 
Last month, Newsom also <a href="https://www.benzinga.com/tech/24/11/42183055/elon-musk-slams-californias-proposal-to-shut-tesla-evs-out-of-consumer-rebates-in-state-this-is-insane">outlined a new proposal</a> to offer incentives for EV buyers in California if Trump gets rid of the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41988194/trump-plans-to-erase-ev-tax-credit-analyst-says-its-net-bullish-calls-sell-off-wrong-knee-jerk-reaction">federal $7,500 tax break</a> for EV buyers when he returns to the White House early next year.
Trump has previously said that he would repeal the approvals granted by the EPA to California for its <a href="https://www.benzinga.com/news/24/08/40092295/trump-opposes-widespread-electric-car-adoption-despite-elon-musks-endorsement-he-is-a-friend-of-mine">push towards electrification of transport.</a> 
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/24/12/42546578/spacex-lost-ground-control-on-dragon-spacecraft-during-polaris-dawn-mission-due-to-power-outage-at-california-facility-report" target="_blank" rel="noreferrer noopener">SpaceX Lost Ground Control On Dragon Spacecraft During Polaris Dawn Mission Due To Power Outage At California Facility: Report</a></li>
</ul>
Photo courtesy: Unsplash

Government

Regulations

EPA Greenlights California's Plan To Ban Sale Of New Gas Cars By 2025

Popular dog-themed cryptocurrency Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) dumped hard Wednesday amid the broader market slump precipitated by the Federal Reserve's hawkish outlook.
What happened: The world's largest meme coin by market capitalization sank to a 5-week low of $0.34 during the evening before clawing back to $0.36.&nbsp;
DOGE lost over 6% in the last 24 hours, while its trading volume spiked 62% to $6.57 billion, making it one of the most transacted tokens on the day.
Well-known cryptocurrency analyst Kevin said that the move down was expected and it was "staring us all in the face."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We predicted this move down on <a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> perfectly. Honestly it was staring us all in the face and was easy to see. If your guru couldn&#39;t spot that one then you should question there talent level <a href="https://t.co/wm5tk3qC0L">https://t.co/wm5tk3qC0L</a>
&mdash; Kevin (@Kev_Capital_TA) <a href="https://twitter.com/Kev_Capital_TA/status/1869531384391553264?ref_src=twsrc%5Etfw">December 18, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Interestingly, a renowned early adopter of the cryptocurrency, Glauber Contessoto, aka the &#8216;Dogecoin Millionaire, &#8216;disclosed on X that he was also among the sellers. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Sorry guys, I had to sell some <a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> <a href="https://t.co/a7pro4wH5S">https://t.co/a7pro4wH5S</a>
&mdash; SlumDOGE Millionaire (@ProTheDoge) <a href="https://twitter.com/ProTheDoge/status/1869580784237171116?ref_src=twsrc%5Etfw">December 19, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:<a href="https://www.benzinga.com/24/12/42519107/if-you-invested-1000-in-bitcoin-when-the-first-bitcoin-etf-was-filed-heres-how-much-youd-have-today"> </a><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42560698/microstrategys-aggressive-bitcoin-strategy-raises-eyebrows-in-crypto-community">MicroStrategy&#8217;s Aggressive Bitcoin Strategy Raises Eyebrows In Crypto Community</a>
Why It Matters: DOGE's technical indicators painted a bearish outlook as of this writing, <a href="https://www.tradingview.com/symbols/DOGEUSDT/technicals/?exchange=BINANCE">according </a>to TradingView.
The Moving Average Convergence Divergence indicator, which compares two exponential moving averages of price, flashed a "Sell" signal. Additionally, most shorter moving averages hinted that the price could fall further.
That said, the Bull Bear Power indicator, used for measuring the strength of buyers and sellers in the market, showed a "Neutral" reading.
The derivatives market, on the other hand, sprang a surprise, as over 84% of the top trader accounts on Binance were long on DOGE as of this writing, <a href="https://www.coinglass.com/TopTrader/Binance">according </a>to Coinglass.
Price Action:&nbsp; At the time of writing, Dogecoin was exchanging hands at $0.3616, down 6.47% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42545656/bitcoin-is-no-manhattan-real-estate-peter-schiff-challenges-microstrategys-micheal-saylor-btc-doesnt-generate-any-income">Bitcoin Is No Manhattan Real Estate, Peter Schiff Challenges MicroStrategy&#8217;s Michael Saylor: &#8216;BTC Doesn&#8217;t Generate Any Income&#8217;</a></li>
</ul>

$DOGE

Dogecoin Bull Says He 'Had To Sell' As Meme King Plunges To 5-Week Low But Derivative Traders Remain Bullish

Macro Economic Events

Econ #s

Economics

Reported Earlier, Japan Interest Rate Decision Unchanged At 0.25%

Comments

Scopus BioPharma

Scopus BioPharma (SCPS) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga